Print ISSN:-
Online ISSN:-2582-1075
Review Article
Author Details :
Volume : 4, Issue : 1, Year : 2022
Article Page : 18-23
https://doi.org/10.18231/j.ijrimcr.2022.003
Abstract
Diabetes mellitus is one of the most common chronic metabolic diseases. Diabetes mellitus can cause many complications such as obesity, stroke, coronary heart disease, diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. Studies show that compared to the cost of treating diabetes, more costs are incurred for the treatment of complications of diabetes. One of the most common chronic complications is diabetic foot ulcers (DFU), which are disabling and affect about 15% of diabetic patients which leading to infection, gangrene, and eventually leading to amputation. DFU care requires a cross-disciplinary and systematic approach consisting of blood glucose control, surgical debridement, vascular recanalization, decompression, and supportive treatment. Controlling wound infection and performing tissue repair is very important to prevent or reduce amputation rates. The concept of negative pressure wound therapy (NPWT) was first established and applied in clinical practice by a German physician, Fleischmann, in 1993 and has been recognized for its remarkable effects in increasing perfusion, improving wound drainage, and promoting the growth of granulation tissue. Currently, NPWT is widely used for various acute and chronic wounds, such as DFU and considered effective to reduce limb amputation rates. NPWT is safe for the treatment of neuropathic, nonischemic, and noninfected plantar ulceration in patients with diabetes mellitus. However, special attention should be given to proper patient selection and intraoperative assessment to ensure wound closure and avoid undue complications.
Keywords: Diabetic foot ulcers, diabetes mellitus, negative pressure wound therapy, VAC, literature review.
How to cite : Sananta P, Huwae* T E C J, Ridwan M, Siahaan L D, Negative Pressure Wound Therapy for the Diabetic Foot Treatment: A Literature Review. Int J Recent Innov Med Clin Res 2022;4(1):18-23
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.